(Q44608567)

4 December 2017

title

Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery (English)

1 reference

4 December 2017

1 reference

1 reference

10

1 reference

4 December 2017

Ajay Niranjan

1

1 reference

4 December 2017

Darren Wolfe

2

1 reference

4 December 2017

Masakazu Tamura

3

1 reference

4 December 2017

M Karina Soares

4

1 reference

4 December 2017

David M Krisky

5

1 reference

4 December 2017

L Dade Lunsford

6

1 reference

4 December 2017

Songhui Li

7

1 reference

4 December 2017

Wendy Fellows-Mayle

8

1 reference

4 December 2017

Neal A DeLuca

9

1 reference

4 December 2017

Joseph C Glorioso

11

1 reference

4 December 2017

publication date

1 October 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

8

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

530-542

1 reference

Assumptions in the radiotherapy of glioblastoma

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Therapeutic irradiation and brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Connexin 43-enhanced suicide gene therapy using herpesviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Replication-defective herpes simplex virus vectors for gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Rapid method for construction of recombinant HSV gene transfer vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Site-specific insertion of DNA into a pseudorabies virus vector

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Possible peptide chain termination mutants in thymide kinase gene of a mammalian virus, herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Radiosurgery for primary malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Stereotactic radiosurgery for recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Radiosurgery and fractionated radiation therapy: comparison of different techniques in an in vivo rat glioma model.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Radiosurgery as part of the initial management of patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

ICP0, a regulator of herpes simplex virus during lytic and latent infection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Bystander tumoricidal effect in the treatment of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Thymidine kinase-mediated killing of rat brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

The role of connexin-mediated cell-cell communication in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Gap junctions: the "kiss of death" and the "kiss of life"

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Radiosurgery: where we were, are, and may be in the third millennium.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Recombinant human tumor necrosis factor enhances radiosensitivity and improves animal survival in murine neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900232-6

7 January 2021

10.1016/S1525-0016(03)00232-6

Identifiers

DOI

1 reference

4 December 2017

1 reference